Actinogen Medical (ATGGF) Financial Statements
Actinogen Medical Financial Overview
Actinogen Medical 's market cap is currently $114.37M. The company's EPS TTM is $-0.00; its P/E ratio is -8.75; Actinogen Medical has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 5.49M | $ 9.93M | $ 4.89M | $ 3.64M |
| Gross Profit | $ -419.27K | $ 5.49M | $ 9.93M | $ 4.48M | $ 3.24M |
| Operating Income | $ -28.11M | $ -14.93M | $ -12.84M | $ -15.87M | $ -13.17M |
| EBITDA | $ -27.69M | $ -14.93M | $ -12.84M | $ -15.22M | $ -12.72M |
| Net Income | $ -15.38M | $ -14.73M | $ -13.04M | $ -10.75M | $ -9.50M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 16.73M | $ 16.50M | $ 9.45M | $ 8.46M | $ 16.37M |
| Total Assets | $ 29.56M | $ 24.48M | $ 21.31M | $ 15.21M | $ 23.31M |
| Total Debt | $ 4.78M | $ 3.26M | $ 319.07K | $ 86.93K | $ 165.27K |
| Net Debt | $ -11.95M | $ -13.24M | $ -9.13M | $ -8.37M | $ -16.21M |
| Total Liabilities | $ 8.18M | $ 6.15M | $ 1.62M | $ 1.80M | $ 1.57M |
| Stockholders' Equity | $ 21.37M | $ 18.34M | $ 19.70M | $ 13.41M | $ 21.74M |
| Cash Flow | |||||
| Free Cash Flow | $ -17.57M | $ -7.59M | $ -16.96M | $ -8.73M | $ -9.52M |
| Operating Cash Flow | $ -17.56M | $ -7.56M | $ -16.95M | $ -8.70M | $ -9.52M |
| Investing Cash Flow | $ -9.29K | $ -38.02K | $ -8.16K | $ -36.60K | $ -2.94K |
| Financing Cash Flow | $ 17.80M | $ 14.65M | $ 17.95M | $ 824.62K | $ 12.42M |
Currency in AUD